poisar

Stocks · News reference

Zuanic & Associates Initiates Coverage On Cronos Group with Overweight Rating

BenzingaBenzinga Newsdesk

Zuanic & Associates analyst Pablo Zuanic initiates coverage on Cronos Group (NASDAQ:CRON) with a Overweight rating.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company

    Cronos Group has completed its acquisition of CanAdelaar B.V., the largest cannabis company in the Netherlands' adult-use cannabis pilot program (Wietexperiment), for a base purchase price of €57.5 million plus contingent cash earnouts. The acquisition establishes Cronos as the market leader in Europe's largest adult-use cannabis market and enables the company to execute its borderless product strategy in the Netherlands with CanAdelaar's proven operational track record and leading market share.

  2. SEC EDGARSEC EDGAR

    8-K filing — Cronos Group Inc. (CRON)

    Filed: 2026-10-15 AccNo: 0001656472-26-000061 Size: 301 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits